Atlas Trials

Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor

Clinical trial NCT02929485 · WITHDRAWN

Trial details

NCT number
NCT02929485
Sponsor
University of California, Berkeley
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Addiction
Start date
2013-07-01
Primary completion
2018-01-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.